Use of intracoronary radiation to prevent restenosis
- Bruce D Klugherz, MD
Bruce D Klugherz, MD
- Medical Director, Cardiac Catheterization Laboratory
- Abington Memorial Hospital, Abington, PA
- Daniel M Kolansky, MD
Daniel M Kolansky, MD
- Professor of Medicine
- University of Pennsylvania School of Medicine
Restenosis has been the principal limitation to the long-term success of percutaneous coronary revascularization. The rate of angiographic restenosis following balloon angioplasty alone (defined as 50 percent or greater reduction in luminal diameter at follow-up angiography) is 40 to 50 percent . About half of the patients with angiographic restenosis manifest clinical restenosis with recurrent ischemia that leads to repeat revascularization of the targeted vessel .
Intracoronary stents, by virtue of their ability to prevent elastic recoil and constrictive remodeling, initially reduced the frequency of angiographic restenosis to approximately 20 percent and the need for repeat revascularization to approximately 10 to 12 percent (figure 1) [3,4]. Even better results have been obtained with drug-eluting stents, which are the stents of choice for most coronary interventions currently (figure 2). (See "Drug-eluting intracoronary stents: General principles".)
Prior to the availability of drug-eluting stents, one major focus of investigation to treat restenosis was the use of intracoronary radiation. Based upon the data presented below, the United States Food and Drug Administration (FDA) has approved both gamma and beta intracoronary radiation for use in the treatment of in-stent restenosis . This technique is applied immediately after mechanical treatment (usually balloon dilatation) of the stent restenosis. However, the increased efficacy of drug-eluting stents for in-stent restenosis has markedly limited the role of intracoronary radiation for this indication.
Data do not support the use of intracoronary radiation for the prevention of restenosis after treating de novo lesions with balloon angioplasty alone, and the FDA has not approved this technique for this indication. (See 'Comparison to drug-eluting stents' below.)
Another radiation approach, insertion of radioactive stents, has been demonstrated to cause an increase in restenosis at the edges of the stent and may delay rather than prevent restenosis within the stent itself. The development of these stents has been discontinued.To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med 1988; 318:265.
- Bengtson JR, Mark DB, Honan MB, et al. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. Am J Cardiol 1990; 65:28.
- Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331:489.
- Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331:496.
- Sapirstein W, Zuckerman B, Dillard J. FDA approval of coronary-artery brachytherapy. N Engl J Med 2001; 344:297.
- Wiedermann JG, Marboe C, Amols H, et al. Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J Am Coll Cardiol 1994; 23:1491.
- Waksman R, Rodriguez JC, Robinson KA, et al. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997; 96:1944.
- Verin V, Popowski Y, de Bruyne B, et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 2001; 344:243.
- Ahmed JM, Mintz GS, Waksman R, et al. Serial intravascular ultrasound analysis of the impact of lesion length on the efficacy of intracoronary gamma-irradiation for preventing recurrent in-stent restenosis. Circulation 2001; 103:188.
- Ahmed JM, Mintz GS, Waksman R, et al. Serial intravascular ultrasound assessment of the efficacy of intracoronary gamma-radiation therapy for preventing recurrence in very long, diffuse, in-stent restenosis lesions. Circulation 2001; 104:856.
- Sabaté M, Marijnissen JP, Carlier SG, et al. Residual plaque burden, delivered dose, and tissue composition predict 6-month outcome after balloon angioplasty and beta-radiation therapy. Circulation 2000; 101:2472.
- Amols HI, Trichter F, Weinberger J. Intracoronary radiation for prevention of restenosis: dose perturbations caused by stents. Circulation 1998; 98:2024.
- Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation : results of a randomized clinical trial. Circulation 2000; 101:360.
- Waksman R, Ajani AE, White RL, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004; 109:340.
- Mintz GS, Weissman NJ, Teirstein PS, et al. Effect of intracoronary gamma-radiation therapy on in-stent restenosis: An intravascular ultrasound analysis from the gamma-1 study. Circulation 2000; 102:2915.
- Ajani AE, Waksman R, Zimarino M, et al. Device selection in the treatment of in-stent restenosis with and without radiation (from the Gamma Radiation Trials). Am J Cardiol 2002; 89:137.
- Park SW, Hong MK, Moon DH, et al. Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon. J Am Coll Cardiol 2001; 38:631.
- Ajani AE, Waksman R, Cha DH, et al. The impact of lesion length and reference vessel diameter on angiographic restenosis and target vessel revascularization in treating in-stent restenosis with radiation. J Am Coll Cardiol 2002; 39:1290.
- Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344:250.
- Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000; 101:2165.
- Gruberg L, Waksman R, Ajani AE, et al. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus. J Am Coll Cardiol 2002; 39:1930.
- Waksman R, Cheneau E, Ajani AE, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 2003; 107:1744.
- Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002; 359:551.
- Waksman R, Bhargava B, White L, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000; 101:1895.
- Suntharalingam M, Laskey W, Lansky AJ, et al. Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002; 52:1075.
- Waksman R, Ajani AE, White RL, et al. Two-year follow-up after beta and gamma intracoronary radiation therapy for patients with diffuse in-stent restenosis. Am J Cardiol 2001; 88:425.
- Stone GW, Ellis SG, O'Shaughnessy CD, et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006; 295:1253.
- Holmes DR Jr, Teirstein P, Satler L, et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006; 295:1264.
- Holmes DR Jr, Teirstein PS, Satler L, et al. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC Cardiovasc Interv 2008; 1:439.
- Waksman R, Ajani AE, White RL, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002; 346:1194.
- Castagna MT, Mintz GS, Waksman R, et al. Comparative efficacy of gamma-irradiation for treatment of in-stent restenosis in saphenous vein graft versus native coronary artery in-stent restenosis: An intravascular ultrasound study. Circulation 2001; 104:3020.
- Serruys PW, Wijns W, Sianos G, et al. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE). J Am Coll Cardiol 2004; 44:528.
- Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336:1697.
- Grise MA, Massullo V, Jani S, et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002; 105:2737.
- Raizner AE, Oesterle SN, Waksman R, et al. Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000; 102:951.
- King SB 3rd, Williams DO, Chougule P, et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998; 97:2025.
- Condado JA, Waksman R, Gurdiel O, et al. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997; 96:727.
- Data presented at the American College of Cardiology 50th Annual Scientific Sessions 2001, Orlando, Florida.
- Ahmed JM, Mintz GS, Waksman R, et al. Safety of intracoronary gamma-radiation on uninjured reference segments during the first 6 months after treatment of in-stent restenosis: a serial intravascular ultrasound study. Circulation 2000; 101:2227.
- Costa MA, Sabaté M, van der Giessen WJ, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100:789.
- Waksman R, Bhargava B, Mintz GS, et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000; 36:65.
- Waksman R. Late thrombosis after radiation. Sitting on a time bomb. Circulation 1999; 100:780.
- Kay IP, Sabate M, Van Langenhove G, et al. Outcome from balloon induced coronary artery dissection after intracoronary beta radiation. Heart 2000; 83:332.
- Salame MY, Verheye S, Mulkey SP, et al. The effect of endovascular irradiation on platelet recruitment at sites of balloon angioplasty in pig coronary arteries. Circulation 2000; 101:1087.
- Ajani AE, Waksman R, Cheneau E, et al. The outcome of percutaneous coronary intervention in patients with in-stent restenosis who failed intracoronary radiation therapy. J Am Coll Cardiol 2003; 41:551.
- Prpic R, Teirstein PS, Reilly JP, et al. Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis. Circulation 2002; 106:2340.
- Waksman R, Ajani AE, White RL, et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001; 103:2332.
- Waksman R, Ajani AE, Pinnow E, et al. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation 2002; 106:776.
- Kim HS, Waksman R, Cottin Y, et al. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol 2001; 37:1026.
- Ahmed JM, Mintz GS, Waksman R, et al. Serial intravascular ultrasound analysis of edge recurrence after intracoronary gamma radiation treatment of native artery in-stent restenosis lesions. Am J Cardiol 2001; 87:1145.
- Meerkin D, Tardif JC, Bertrand OF, et al. The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections. J Am Coll Cardiol 2000; 36:59.
- Scheinert D, Strnad V, Müller R, et al. High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasm. Circulation 2002; 105:1420.
- Waksman R, Weinberger J. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive. Circulation 2003; 108:386.
- Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124:e574.
- GENERAL PRINCIPLES
- Radiation dose
- Scattering after stenting
- Use for in-stent restenosis
- - Comparison to drug-eluting stents
- - Saphenous vein grafts
- De novo stenting
- Use for restenosis after PTCA
- Use after angioplasty alone
- Effect on normal coronary segments
- Late thrombosis
- Prolonged dual antiplatelet therapy
- Edge stenosis
- Delayed healing of dissections
- Coronary artery spasm